Daiwa Securities Group Inc. Bristol Myers Squibb CO Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 508,086 shares of BMY stock, worth $22.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
508,086
Previous 424,659
19.65%
Holding current value
$22.3 Million
Previous $25.9 Million
9.19%
% of portfolio
0.09%
Previous 0.11%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,674Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.57 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.97 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.75 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.16 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.11 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $93.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...